Syndax Pharmaceuticals Inc (NAS:SNDX)
$ 20.28 0.17 (0.85%) Market Cap: 1.72 Bil Enterprise Value: 1.28 Bil PE Ratio: 0 PB Ratio: 3.50 GF Score: 53/100

Syndax Pharmaceuticals Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 08:35PM GMT
Release Date Price: $23.67 (+1.59%)
Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

Great. Thank you. Good afternoon, everyone. My name is Pete Lawson. I'm one of the biotech analysts at Barclays, and welcome to Barclays Global Healthcare Conference. I just wanted to thank everyone for taking time out that day. And we've got management team from Syndax. If you've got questions, institutional investors can e-mail me at [email protected] or ping me on Bloomberg and my pleasure to introduce the management team from Syndax. So we've got the full suite of management essentially. Briggs, Daphne, Michael, and Anjali, and it's my pleasure to speak to you guys today, and thanks for joining. And I guess, just to kick things off.

Questions & Answers

Peter Richard Lawson
Barclays Bank PLC, Research Division - Research Analyst

I guess the question I've been asking today has just been around like the company's differentiation in the oncology space is plenty of oncology companies, what do you kind of view as the differentiation? What are your core competencies in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot